Huntington's disease

被引:32
作者
Ross, CA
Margolis, RL
机构
[1] Johns Hopkins Univ, Sch Med, Div Neurobiol, Mol Neurobiol Lab,Dept Psychiat, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Div Neurobiol, Lab Genet Neurobiol,Dept Psychiat, Baltimore, MD 21205 USA
基金
美国国家卫生研究院;
关键词
Huntington; trinucleotide repeat; glutamine; neurodegeneration; movement; psychiatric;
D O I
10.1016/S1566-2772(00)00014-1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
dHuntington's disease (HD) is an autosomal dominant progressive neuropyschiatric disorder, characterized h abnormalities of movement, emotion and cognition. The most important pathologgical feature is selective neuronal loss, primarily in the striatum and cerebral cortex. HD is caused by the expansion of a CAG trinucleotide repeat in the gene encoding humingtin. The expanded repeat encodes an abnormally long polyglutamine tract, and many lines of evidence no strongly suggest that this mutation is neurotoxic. In this review, we first detail the clinical, genetic and pathological features of HID. We then describe how clues from neurotoxicological, biochemical, cell, transgenic mouse, and invertebrate models of HD lead to a multifactored model of HD pathogenesis,. We Conclude h discussing how the model of HD serves as a guide to the development of rational therapeutics for this devastating disease. (C) 2001 Association for Research in Nervous and Mental Disease. All rights reserved.
引用
收藏
页码:142 / 152
页数:11
相关论文
共 103 条
  • [1] PREFERENTIAL LOSS OF STRIATO-EXTERNAL PALLIDAL PROJECTION NEURONS IN PRESYMPTOMATIC HUNTINGTONS-DISEASE
    ALBIN, RL
    REINER, A
    ANDERSON, KD
    DURE, LS
    HANDELIN, B
    BALFOUR, R
    WHETSELL, WO
    PENNEY, JB
    YOUNG, AB
    [J]. ANNALS OF NEUROLOGY, 1992, 31 (04) : 425 - 430
  • [2] STRUCTURE AND EXPRESSION OF THE HUNTINGTONS-DISEASE GENE - EVIDENCE AGAINST SIMPLE INACTIVATION DUE TO AN EXPANDED CAG REPEAT
    AMBROSE, CM
    DUYAO, MP
    BARNES, G
    BATES, GP
    LIN, CS
    SRINIDHI, J
    BAXENDALE, S
    HUMMERICH, H
    LEHRACH, H
    ALTHERR, M
    WASMUTH, J
    BUCKLER, A
    CHURCH, D
    HOUSMAN, D
    BERKS, M
    MICKLEM, G
    DURBIN, R
    DODGE, A
    READ, A
    GUSELLA, J
    MACDONALD, ME
    [J]. SOMATIC CELL AND MOLECULAR GENETICS, 1994, 20 (01) : 27 - 38
  • [3] THE RELATIONSHIP BETWEEN TRINUCLEOTIDE (CAG) REPEAT LENGTH AND CLINICAL-FEATURES OF HUNTINGTONS-DISEASE
    ANDREW, SE
    GOLDBERG, YP
    KREMER, B
    TELENIUS, H
    THEILMANN, J
    ADAM, S
    STARR, E
    SQUITIERI, F
    LIN, BY
    KALCHMAN, MA
    GRAHAM, RK
    HAYDEN, MR
    [J]. NATURE GENETICS, 1993, 4 (04) : 398 - 403
  • [4] Longitudinal change in basal ganglia volume in patients with Huntington's disease
    Aylward, EH
    Li, Q
    Stine, OC
    Ranen, N
    Sherr, M
    Barta, PE
    Bylsma, FW
    Pearlson, GD
    Ross, CA
    [J]. NEUROLOGY, 1997, 48 (02) : 394 - 399
  • [5] REPLICATION OF THE NEUROCHEMICAL CHARACTERISTICS OF HUNTINGTONS-DISEASE BY QUINOLINIC ACID
    BEAL, MF
    KOWALL, NW
    ELLISON, DW
    MAZUREK, MF
    SWARTZ, KJ
    MARTIN, JB
    [J]. NATURE, 1986, 321 (6066) : 168 - 171
  • [6] BEAL MF, 1993, J NEUROSCI, V13, P4181
  • [7] Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: Correlation between the density of inclusions and IT15 CAG triplet repeat length
    Becher, MW
    Kotzuk, JA
    Sharp, AH
    Davies, SW
    Bates, GP
    Price, DL
    Ross, CA
    [J]. NEUROBIOLOGY OF DISEASE, 1998, 4 (06) : 387 - 397
  • [8] BOSS CA, 1998, GENETIC INSTABILITIE
  • [9] Aberrant interactions of transcriptional repressor proteins with the Huntington's disease gene product, huntingtin
    Boutell, JM
    Thomas, P
    Neal, JW
    Weston, VJ
    Duce, J
    Harper, PS
    Jones, AL
    [J]. HUMAN MOLECULAR GENETICS, 1999, 8 (09) : 1647 - 1655
  • [10] DIFFERENTIAL COGNITIVE IMPAIRMENT IN ALZHEIMERS-DISEASE AND HUNTINGTONS-DISEASE
    BRANDT, J
    FOLSTEIN, SE
    FOLSTEIN, MF
    [J]. ANNALS OF NEUROLOGY, 1988, 23 (06) : 555 - 561